Publications by authors named "D J Steiger"
Background: Interhospital transfer (IHT) for acute pulmonary embolism (PE) is increasingly performed to improve access to advanced reperfusion therapies. It is unclear if outcomes of patients undergoing IHT are comparable with those of patients presenting in-house to hospitals with PE Response Team (PERT) capabilities.
Objectives: To determine whether outcomes of patients with acute PE undergoing IHT differ from those of patients presenting in-house.
Article Synopsis
- The study investigated how common pulmonary embolism (PE) is in sepsis patients, both with and without septic shock, using data from the National Inpatient Sample between 2017 and 2019.
- It found that 1.2% of patients with sepsis without shock and 2.3% with septic shock developed PE, which significantly increases the risk of in-hospital mortality, with an odds ratio of 1.94.
- Additionally, having PE was linked to longer hospital stays and higher costs, with an average increase in costs of approximately $46,513 per hospitalization.
Background Therapeutic anticoagulation is the cornerstone of treatment for pulmonary embolism (PE), but the impact of different anticoagulation strategies on patient outcomes remains unclear. In this study, we assessed the association of different anticoagulation strategies with the outcomes of patients with acute PE. Methods A retrospective chart review of 207 patients with acute PE who were admitted to one of three urban teaching hospitals in the Mount Sinai Health System (in New York City) from January 2020 to September 2022 was performed.
View Article and Find Full Text PDFBackground: Management of PE has become streamlined with the implementation of PE Response Teams (PERT). Race, ethnicity and insurance status are known to influence the outcomes of patients with acute PE. However, whether the implementation of PERT-based care mitigates these racial and ethnic disparities remains unknown.
View Article and Find Full Text PDFThe emerging European Health Data Space (EHDS) Regulation opens new prospects for large-scale sharing and re-use of health data. Yet, the proposed regulation suffers from two important limitations: it is designed to benefit the whole population with limited consideration for individuals, and the generation of secondary datasets from heterogeneous, unlinked patient data will remain burdensome. AIDAVA, a Horizon Europe project that started in September 2022, proposes to address both shortcomings by providing patients with an AI-based virtual assistant that maximises automation in the integration and transformation of their health data into an interoperable, longitudinal health record.
View Article and Find Full Text PDF